Natalee Bales

Epic Sciences (United States) — United States

Medicine · Health Sciences

6h-index320citations14works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(10), Prostate Cancer Treatment and Research(7), Cancer Genomics and Diagnostics(5), Lung Cancer Treatments and Mutations(2), Cancer, Hypoxia, and Metabolism(2)

Publications14 total

Phenotypic diversity of circulating tumour cells in patients with metastatic castration‐resistant prostate cancer
British Journal of Urology·2016· 65 citedOpen Access
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
British Journal of Cancer·2015· 89 citedOpen Access
Abstract 1586: Recovery and characterization of circulating tumor cells (CTCs) in cryopreserved metastatic castrate-resistant prostate cancer (mCRPC) patient samples
Cancer Research·2015· 1 cited
Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear Cells
Journal of Circulating Biomarkers·2015· 11 citedOpen Access
Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear Cells
Journal of Circulating Biomarkers·2015Open Access
Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization
Journal of Circulating Biomarkers·2015· 14 citedOpen Access
Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization
Journal of Circulating Biomarkers·2015· 122 citedOpen Access
397 Characterization of molecular targets of therapy in Non-Small Cell Lung Cancer (NSCLC) utilizing a liquid biopsy
European Journal of Cancer·2014
Abstract 2841: Characterization of ALK fusions in circulating tumor cells (CTCs) of NSCLC
Cancer Research·2014· 1 cited
Abstract 4819: Evaluation of PTEN status in circulating tumor cells (CTCs) and matched tumor tissue from castrate-resistant prostate cancer (CRPC) patients
Cancer Research·2014
Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC).
Journal of Clinical Oncology·2014· 1 cited
CK- and small nuclear size circulating tumor cell (CTCs) phenotypes in metastatic castration-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology·2014· 5 cited
Sequential monitoring and characterization of circulating tumor cells (CTCs) using the epic sciences platform in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with recently approved therapeutics.
Journal of Clinical Oncology·2014· 5 cited
Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in progressive metastatic castration resistant prostate cancer (mCRPC).
Journal of Clinical Oncology·2014· 6 cited

Frequent Co-authors

Dena Marrinucci(14), Ryan Dittamore(12), Jessica Louw(12), Rachel Krupa(10), Mark Landers(6), Ryon P. Graf(5), Gerhardt Attard(5), Johann S. de Bono(5), Roberta Ferraldeschi(4), Eric Tucker(4), Melissa Harvey(4), Shannon L. Werner(3), Penelope Flohr(3), Ruth Riisnaes(3), Ines Figueiredo(3), David Lu(3), Ravi A. Madan(3), Christopher R. Heery(3), Jennifer L. Marté(3), Sharon Beasley(3)